 Connection
Caroline Dias to Epigenesis, Genetic
This is a "connection" page, showing publications Caroline Dias has written about Epigenesis, Genetic.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.248 |
|
|
|
-
Doss RM, Lopez-Ignacio S, Dischler A, Hiatt L, Dashnow H, Breuss MW, Dias CM. Mosaicism in Short Tandem Repeat Disorders: A Clinical Perspective. Genes (Basel). 2025 Feb 13; 16(2).
Score: 0.154
-
Koo JW, Mazei-Robison MS, LaPlant Q, Egervari G, Braunscheidel KM, Adank DN, Ferguson D, Feng J, Sun H, Scobie KN, Damez-Werno DM, Ribeiro E, Peña CJ, Walker D, Bagot RC, Cahill ME, Anderson SA, Labonté B, Hodes GE, Browne H, Chadwick B, Robison AJ, Vialou VF, Dias C, Lorsch Z, Mouzon E, Lobo MK, Dietz DM, Russo SJ, Neve RL, Hurd YL, Nestler EJ. Epigenetic basis of opiate suppression of Bdnf gene expression in the ventral tegmental area. Nat Neurosci. 2015 Mar; 18(3):415-22.
Score: 0.077
-
Robison AJ, Vialou V, Sun HS, Labonte B, Golden SA, Dias C, Turecki G, Tamminga C, Russo S, Mazei-Robison M, Nestler EJ. Fluoxetine epigenetically alters the CaMKIIa promoter in nucleus accumbens to regulate ?FosB binding and antidepressant effects. Neuropsychopharmacology. 2014 Apr; 39(5):1178-86.
Score: 0.018
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|